In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
EMBRYO-FETAL TOXICITY: DO NOT ADMINISTER VERICIGUAT TO A PREGNANT FEMALE BECAUSE IT MAY CAUSE FETAL HARM.
FEMALES OF REPRODUCTIVE POTENTIAL: EXCLUDE PREGNANCY BEFORE THE START OF TREATMENT. TO PREVENT PREGNANCY, FEMALES OF REPRODUCTIVE POTENTIAL MUST USE EFFECTIVE FORMS OF CONTRACEPTION DURING TREATMENT AND FOR ONE MONTH AFTER STOPPING TREATMENT.
See full prescribing information for complete boxed warning
Please login to view the rest of this drug profile.